Assignee
TOCAGEN INC
US·6 granted patents·5 pending applications·8 citations·filing 2013–2019
Top patents by PatentIndex Score
11 records- 0181US9732326B2Recombinant vectorsTOCAGEN INC·Filed 2014·Granted Aug 15, 2017·3 cites·24 claims
- 0279US10035983B2Gene therapy vectors and cytosine deaminasesTOCAGEN INC·Filed 2014·Granted Jul 31, 2018·3 cites·6 claims
- 0375US2020239858A1Recombinant vectorsTOCAGEN INC·Filed 2019·Application pending·0 cites
- 0474US9889133B2Formulations of 5-fluorocytosine and uses thereofTOCAGEN INC·Filed 2016·Granted Feb 13, 2018·1 cites·18 claims
- 0573US9642921B2Cancer combination therapy and recombinant vectorsTOCAGEN INC·Filed 2013·Granted May 9, 2017·1 cites·14 claims
- 0663US10449194B2Formulations of 5-fluorocytosine and uses thereofTOCAGEN INC·Filed 2018·Granted Oct 22, 2019·0 cites·13 claims
- 0762US10407666B2Recombinant vectorsTOCAGEN INC·Filed 2017·Granted Sep 10, 2019·0 cites·10 claims
- 0857US2018021365A1Enhanced cancer treatment and monitoring using recombinant vectorsTOCAGEN INC·Filed 2017·Application pending·0 cites
- 0956US2019185821A1Gene therapy vectors and cytosine deaminasesTOCAGEN INC·Filed 2018·Application pending·0 cites
- 1044US2016175388A1Immunosuppressive components associated with retroviral replicating vectorsTOCAGEN INC·Filed 2014·Application pending·0 cites
- 1139US2016222412A1Recombinant vector with stabilizing a-loopTOCAGEN INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TOCAGEN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →